DK0542979T3 - Therapeutic composition for slow release of magnesium - Google Patents
Therapeutic composition for slow release of magnesiumInfo
- Publication number
- DK0542979T3 DK0542979T3 DK92912677T DK92912677T DK0542979T3 DK 0542979 T3 DK0542979 T3 DK 0542979T3 DK 92912677 T DK92912677 T DK 92912677T DK 92912677 T DK92912677 T DK 92912677T DK 0542979 T3 DK0542979 T3 DK 0542979T3
- Authority
- DK
- Denmark
- Prior art keywords
- magnesium
- weight
- mgo
- parts
- source
- Prior art date
Links
- 239000011777 magnesium Substances 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 4
- 229910052749 magnesium Inorganic materials 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 4
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- -1 fatty acid esters Chemical class 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 1
- MJMDTFNVECGTEM-UHFFFAOYSA-L magnesium dichloride monohydrate Chemical class O.[Mg+2].[Cl-].[Cl-] MJMDTFNVECGTEM-UHFFFAOYSA-L 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a new therapeutic composition useful for magnesic deficiencies to enterically release the magnesium contained therein in a slow and continuous way, said composition being characterized in that it is comprised of a mixture containing, in association with a physiologically acceptable vehicle, (A) from 4 to 14 parts by weight of magnesium from a magnesium source comprised of MgO, MgCl2? and the magnesium chloride hydrates having the formula MgCl2?, nH2?O where n is an integer or fractional number higher than 0 and not exceeding 6, and (B) from 6 to 13 parts by weight of a hydrophilic polymer, when the source of Mg is MgO, or from 10 to 30 parts by weight of a hydrophobic substance selected amongst the group including the physiologically acceptable hydrophobic polymers, the fatty acid esters and mixtures thereof, when the source Mg is different from MgO, the Mg content in said mixture being between 5 and 60 % by weight based on the weight of said mixture.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107141A FR2677546B1 (en) | 1991-06-12 | 1991-06-12 | THERAPEUTIC COMPOSITION FOR EXTENDED RELEASE OF MAGNESIUM. |
| PCT/FR1992/000534 WO1992022305A1 (en) | 1991-06-12 | 1992-06-12 | Therapeutic composition for sustained release of magnesium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0542979T3 true DK0542979T3 (en) | 1999-01-04 |
Family
ID=9413736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92912677T DK0542979T3 (en) | 1991-06-12 | 1992-06-12 | Therapeutic composition for slow release of magnesium |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0542979B1 (en) |
| JP (1) | JPH06503096A (en) |
| AT (1) | ATE164071T1 (en) |
| DE (1) | DE69224793T2 (en) |
| DK (1) | DK0542979T3 (en) |
| ES (1) | ES2117049T3 (en) |
| FR (1) | FR2677546B1 (en) |
| WO (1) | WO1992022305A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887492B2 (en) | 2000-12-14 | 2005-05-03 | Leiner Health Services Corp. | Magnesium plus interactive agent delivery |
| FR2855412B1 (en) * | 2003-05-27 | 2007-05-25 | Menvielle Bourg Fabienn Joanny | EXTENDED MAGNESIUM RELEASE COMPOSITION AND ITS APPLICATION IN THE THERAPEUTIC, COSMETIC AND NUTRITIONAL FIELD |
| FR2931361B1 (en) | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | MAGNESIUM-BASED SYSTEM AND ITS USE IN COSMETICS |
| FR2931359B1 (en) | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | USE OF MATRIX FOR EXTENDED RELEASE MAGNESIUM ORAL DELIVERY, AND COMPOSITION CONTAINING SAME |
| EP2813217A1 (en) | 2013-06-11 | 2014-12-17 | Fabienne Joanny Menvielle-Bourg | Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422193A (en) * | 1974-07-26 | 1976-01-21 | Smith Kline French Lab | Pharmaceutical compositions |
| CH677612A5 (en) * | 1987-09-11 | 1991-06-14 | Ciba Geigy Ag | |
| GB8809421D0 (en) * | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
| US5002774A (en) * | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
-
1991
- 1991-06-12 FR FR9107141A patent/FR2677546B1/en not_active Expired - Fee Related
-
1992
- 1992-06-12 DE DE69224793T patent/DE69224793T2/en not_active Expired - Fee Related
- 1992-06-12 WO PCT/FR1992/000534 patent/WO1992022305A1/en not_active Ceased
- 1992-06-12 EP EP92912677A patent/EP0542979B1/en not_active Expired - Lifetime
- 1992-06-12 ES ES92912677T patent/ES2117049T3/en not_active Expired - Lifetime
- 1992-06-12 DK DK92912677T patent/DK0542979T3/en active
- 1992-06-12 JP JP5500766A patent/JPH06503096A/en active Pending
- 1992-06-12 AT AT92912677T patent/ATE164071T1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06503096A (en) | 1994-04-07 |
| WO1992022305A1 (en) | 1992-12-23 |
| EP0542979B1 (en) | 1998-03-18 |
| EP0542979A1 (en) | 1993-05-26 |
| FR2677546B1 (en) | 1994-01-21 |
| FR2677546A1 (en) | 1992-12-18 |
| DE69224793D1 (en) | 1998-04-23 |
| ATE164071T1 (en) | 1998-04-15 |
| ES2117049T3 (en) | 1998-08-01 |
| DE69224793T2 (en) | 1998-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69206214D1 (en) | New arylethylamine derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
| EE02958B1 (en) | Prolonged - release preparation, polymer blend for its preparation and polymer blend preparation method | |
| CA2009890A1 (en) | Valproic acid | |
| GB1520197A (en) | Stable antibiotic compositions | |
| HUP0300388A2 (en) | Coating and binding agent for pharmaceutical formulations with improved storage stability | |
| MY139606A (en) | Sustained-release composition and process for producing the same | |
| ES8207169A1 (en) | 4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use | |
| DK0542979T3 (en) | Therapeutic composition for slow release of magnesium | |
| MX9307107A (en) | COMPOSITION OF RETICULATED POLYMERS. | |
| ES2174930T3 (en) | METRONIDAZOL COMPOSITIONS OF MODIFIED LIBERATION AND METHODS TO PREPARE AND USE THE SAME. | |
| BR9912706A (en) | Pharmaceutical compositions containing ibuprofen and domperidone | |
| CA2357114A1 (en) | Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder | |
| JPS5531803A (en) | Polyamide composition | |
| JPS5726587A (en) | Stabilization of ascorbic acid oxidase | |
| JPS6430A (en) | Gradually releasing preparation | |
| SU763396A1 (en) | Rubber mixture | |
| JPS55112202A (en) | Antisticking composition for unvulcanized rubber | |
| JPS5650958A (en) | Resin composition | |
| JPS5444034A (en) | Easily absorbable nifedipine composition and anti- stenocardia containing said composition | |
| ES445404A1 (en) | O,O-dialkyl-5-halo-pyrimidin(2) yl-thionophosphoric acid esters | |
| KR950016755A (en) | Pharmaceutical composition for the prevention and treatment of hepatitis | |
| JPS5455562A (en) | Lactam compound | |
| JPS55164239A (en) | Heat stabilizer composition for polyvinyl chloride | |
| JPS5241244A (en) | Sustained release aromatic composition and method of making the same | |
| ATE159055T1 (en) | METALLOTHERMAL REACTION MIXTURE |